Investment Summary |
|
---|---|
Date | 2014-10-08 |
Target | Ingo Money |
Sector | Internet Software and Services |
Investor(s) |
Camden Partners
Spring Capital Partners |
Deal Type | Growth Capital |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1995 |
PE ASSETS | 700M USD |
Size | Middle-Market |
Type | Sector Agnostic |
Camden Partners is a growth-oriented private investment firm focused on direct investments as well as structured capital solutions. Camden's direct private equity practice targets equity investments up to $15 million in businesses operating in the technology, software, business services, and education sectors. Prospective companies generally have proven management, proprietary products or high barriers to entry, recurring revenue, and proven business models. Camden Partners was formed in 1995 and is based in Baltimore, Maryland.
DEAL STATS | # |
---|---|
Overall | 29 of 37 |
Sector (Internet Software and Services) | 3 of 4 |
Type (Growth Capital) | 8 of 13 |
State (Georgia) | 3 of 3 |
Country (United States) | 28 of 36 |
Year (2014) | 3 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-07-23 |
LifeNexus
San Francisco, California, United States LifeNexus is a creator of the patented iChip technology, a mobile platform that delivers personalized health information and analytics to consumers and their doctors. LifeNexus is based in San Francisco, California. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-10-29 |
Paragon Bioservices
Baltimore, Maryland, United States Paragon Bioservices, Inc. is a contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon aims to build strong client partnerships with the world’s best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses), and other complex biologics. Paragon Bioservices, Inc. was founded in 1990 and is based in Baltimore, Maryland. |
Buy | - |
Category | Mezzanine Finance Firm |
---|---|
Founded | 1999 |
PE ASSETS | 600M USD |
Size | Middle-Market |
Type | Sector Agnostic |
Spring Capital Partners is a mezzanine finance provider for small to medium-sized businesses. Spring invests $2 to $20 million, primarily in the form of subordinated debt with equity features in each transaction. The Firm does not have an industry focus. Spring Capital looks for businesses located in the Mid-Atlantic US with revenues between $10 and $150 million. Spring Capital Partners was formed in 1999 and has offices in Baltimore, Maryland and Radnor, Pennsylvania.
DEAL STATS | # |
---|---|
Overall | 27 of 45 |
Sector (Internet Software and Services) | 2 of 3 |
Type (Growth Capital) | 9 of 16 |
State (Georgia) | 1 of 1 |
Country (United States) | 27 of 45 |
Year (2014) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-09-17 |
HomeCentris Healthcare
Owings Mills, Maryland, United States HomeCentris Healthcare provides home health aides, skilled nursing, and physical, occupational, and speech therapies to Medicare customers. HomeCentris Healthcare was founded in 2014 and is based in Owings Mills, Maryland. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-01-15 |
NextPhase Medical Devices
Waldwick, New Jersey, United States NextPhase Medical Devices is specialized in design, development and a manufacturing partner that helps OEMs bring low- to medium-volume complex medical devices. NextPhase Medical Devices was founded in 1999 and is based in Waldwick, New Jersey. |
Buy | - |